Monday, July 4, 2022

SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Significant Drop in Short Interest

It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies ...
https://www.google.com/url?rct=j&sa=t&url=https://www.etfdailynews.com/2022/07/04/sab-biotherapeutics-inc-nasdaqsabs-sees-significant-drop-in-short-interest/&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AOvVaw28HTKPC7IdBprUSzRmNzrw

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...